HealthQuill Articles by: HealthQuill
medicines
Drugs Health Medical

Michigan Univ study links herbal supplements to liver damage risk

HQ Team August 19, 2024: Herbs have been utilized for medicinal purposes for thousands of years. Herbal supplements, including well-known products like ashwagandha,

Read More
After screening 12 million commercially available compounds using AI, researchers at the Massachusetts Institute of Technology have discovered a drug candidate to terminate a potentially fatal skin bacteria.
Drugs Health Medical

Researchers uncover key role of gut cells in triggering gluten allergy

HQ Team August 17, 2024: A team of scientists led by McMaster University in Canada has found that cells lining the gut play

Read More
Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and a video game using the device, according to a video posted by billionaire Elon Musk’s X platform.
Drugs Health Medical

Study finds 25% of severe brain injury patients show cognitive awareness

HQ Team August 17, 2024: A new study reveals that one in four patients suffering from brain injury show some cognitive function during

Read More
German biotechnology company, BioNTech SE announced a $ 90 million program in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a  vaccine for mpox.
Drugs Health Medical

Sweden confirms first case of Mpox outside Africa

HQ Team August 15, 2024: Sweden confirmed its first case of the most virulent form of Mpox Thursday, a viral infection found in

Read More
Drugs Health Medical

Breakthrough gene therapy restores hearing in children with inherited deafness

HQ Team August15, 2024: A clinical trial has successfully restored hearing in five children suffering from inherited deafness by administering gene therapy to

Read More
Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.
Health Medical Pharma

J&J’s $6.5B settlement plan amid ongoing talc lawsuits finds favour

HQ Team August 14, 2024: Johnson & Johnson (J&J) is nearing settlement of lawsuits alleging that its talc-based baby powder caused cancer. Over

Read More
Researchers at the University of Central Florida have engineered a human tissue that draws mosquitoes to bite and feed on, and hope the platform can help study the pattern of how the pathogens the insects carry impact and infect human cells and tissues.
Climate Health Medical

Oropouche virus spreads across Latin America and Europe

HQ Team August 14, 2024: The Oropouche virus (OROV), primarily transmitted by biting midges (flies) and mosquitoes, is spreading in Latin America, with

Read More
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,” after a single jab, according to a company statement. 
Drugs Health Pharma

‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says

Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”

Read More
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and paediatric patients.
Drugs Health Pharma

US-based ARS’s nasal spray to treat allergic reactions gets FDA nod

ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and

Read More
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.
Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data 

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory

Read More